Keyword: Merck & Co.

News

Merck & Co Wades into Covid Vaccine Race

28.05.2020 - US pharma giant Merck & Co is wading into the race to find a vaccine or treatment for Covid-19. The New Jersey-based company is joining forces with nonprofit research group IAVI on...

Markets & Companies

Vaccine Research – an Ambitious and Important Venture

20.04.2020 - The worldwide spread of the corona virus shows once again that despite all technological progress, humanity is still exposed to health risks. The biotech and pharmaceutical...

News

US Merck to Spin off $6.5 Billion in Assets

07.02.2020 - US drugmaker Merck plans to streamline its organization by spinning off assets with around $6.5 billion in annual revenue. Businesses to be separated out by the first half of 2021...

News

Merck & Co. Takes Calporta for $576 Million

26.11.2019 - US Merck & Co. has agreed to buy Calporta Therapeutics for up to $576 million, including an upfront sum and contingent milestone payments. Calporta was launched in early 2015 by...

News

Merck & Co Sheds more than 200 French Jobs

15.11.2019 - US Merck & Co. is eliminating 200 manufacturing and R&D jobs in France as part of a $1.2 billion worldwide restructuring of operations. The axe will fall on 101 production and 106...

News

US Supreme Court Remands Fosamax Suits to Appeals

31.05.2019 - A recent decision by the US Supreme Court to remand a number of product liability lawsuits against US drugmaker Merck & Co to an appeals court has peaked the pharmaceutical...

News

Merck Restructure to Cut Jobs

02.05.2019 - US drugmaker Merck & Co. has begun a restructuring program of its manufacturing and supply network, as well as reducing its global real estate footprint. The disclosure was made in...

News

IRBM and Merck & Co Cooperate on Peptides

12.09.2018 - Italian research organization IRBM has signed a new agreement with Merck & Co on peptides therapeutics, extending a collaboration begun in 2010. In the newest round, it will...